Content - Young Oncology Academy

Young Oncology Academy

Many more patients will develop cancer in the near future and the improved therapeutic options will increase the length of treatment. Identification of driver mutations leads to a further fragmentation of cancer diagnoses and results in a rapidly increasing complexity and thus sub-specialization in the field.

In order to successfully deal will these imminent challenges the promotion of talented young oncologists is vital. This program should help to identify and train young oncologists to become active players in clinical and translational research, to learn how to take responsibility for a trial and how to successfully run and publish a study.

Call for the Young Oncology Academy 2018

Young Oncology Academy

Residents at the beginning of their medical career with a clear focus on cancer medicine, hematology or radio-oncology.

Get involved in order to gain

  1. knowledge in oncology
  2. presentation skills
  3. networking opportunity
  4. writing skills
  5. insights in trial development

Please find further information about the detailed program in our Curriculum.

20.04.–24.04.: ESTRO congress, Barcelona (Radio-Oncologists)
14.06.–17.06.: EHA congress, Stockholm (Hematologists)
19.10.–23.10.: ESMO congress, Munich (Oncologists)
17.05.–18.05.: Presentation skill course, University of Lausanne
04.10.–05.10.: Writing skill course, Kantonsspital Winterthur
08.11.: 1st presentation, Hotel St. Gotthard Zürich
22.11.: 2nd presentation, SAKK semi-annual meeting, Hotel Marriott Zürich


Chair: Prof. Dr. med. Miklos Pless, Kantonsspital Winterthur
Prof. Dr. med. Ulrich Güller, Kantonsspital St. Gallen
PD Dr. med. Richard Cathomas, Kantonsspital Graubünden, Chur
PD Dr. med. Dr. phil. nat. Sacha Rothschild, Universitätsspital Basel
PD Dr. med. Urban Novak, Inselspital, Bern
Prof. Dr. med. Gabriela Baerlocher, Inselspital, Bern
Prof. Dr. med. Stephan Bodis, Kantonsspital Aarau

The application window for the YOA 2018 is closed. The application period for the YOA 2019 starts in November 2018.



This SAKK activity is supported by Bayer (Schweiz) AG, Takeda Pharma AG, and Merck (Schweiz) AG. The companies are committed to support this medical education event without intention to influence prescribing, supply or recommendation of any of their products.

Bayer (Schweiz) AG, Takeda Pharma AG, Merck (Schweiz) AG